Dementia, depression, and heart failure: Central role of brain-derived neurotrophic factor and possible common
Aleksandra Sustar1, Sergej Nadalin2, Nela Pivac3
1Division of Cardiology, Department of Internal Medicine, Spital Uster, Uster, Canton of Zurich, Switzerland.
Insights
Heart failure (HF) is linked to cognitive impairment and depression due to complex heart-brain interactions. Understanding these mechanisms, particularly brain-derived neurotrophic factor (BDNF), may reveal new treatments for mental health in HF patients.
Area of Science:
- Neuroscience
- Cardiology
- Psychiatry
Background:
- Heart failure (HF) is a complex syndrome with significant neuropsychiatric effects.
- Cognitive impairment and depression are prevalent in HF patients, worsening outcomes.
- The underlying neurobiology of these comorbidities remains incompletely understood.
Purpose of the Study:
- To review the neurobiological mechanisms linking HF, depression, and dementia.
- To highlight the role of the heart-brain axis and brain-derived neurotrophic factor (BDNF).
- To explore potential therapeutic targets for improving mental and cognitive health in HF.
Main Methods:
- Literature review of neuroendocrine, inflammatory, and neuroplastic mechanisms.
- Focus on the integrative heart-brain axis.
- Emphasis on BDNF's role in synaptic plasticity and stress resilience.
Main Results:
- Converging evidence links HF to altered hypothalamic-pituitary-adrenal (HPA) axis activity.
- Systemic inflammation and impaired BDNF signaling are key mediators.
- These factors contribute to cognitive decline and depression in HF.
Conclusions:
- Understanding the interplay between HF, HPA axis, inflammation, and BDNF is crucial.
- Novel multimodal therapies targeting neurotrophic pathways show promise.
- Improving cognitive and mental health outcomes in HF patients is a key goal.
Abstract:
Heart failure (HF) is a complex systemic syndrome with major neuropsychiatric consequences. Cognitive impairment (e.g., dementia) and depression are common among HF patients, worsening prognosis, increasing hospital admissions, and impairing quality of life. Despite their prevalence, the neurobiological basis of these comorbidities is not yet fully understood. This review uniquely discusses converging neuroendocrine, inflammatory, and neuroplastic mechanisms linking HF, depression, and dementia inside an integrative heart-brain axis highlighting brain-derived neurotrophic factor (BDNF) as an important modulator of synaptic plasticity, neurogenesis, and stress resilience. Understanding the interactions between HF-induced hypothalamic-pituitary-adrenal axis activation, systemic inflammation, and impaired BDNF signaling may contribute to the development of novel multimodal therapeutic strategies targeting neurotrophic pathways and improving cognitive and mental health outcomes in HF.
Related Concept Videos
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Gut-Brain Axis
Alzheimer's Disease: Treatment
Neurogenesis and Regeneration of Nervous Tissue
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neurotransmitters


